Across TCGA pan-cancer cohorts, MAILR RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MAILR data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher MAILR RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MAILR expression acts as an unfavorable survival marker, although some lineages such as ACC and UCEC show a favorable association.
UVM, ACC, and KIRP are the cancer types where MAILR RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.